Effects of Strontium Ranelate and Alendronate on Bone Microstructure in Women With Osteoporosis

Osteoporosis International - United Kingdom
doi 10.1007/s00198-011-1758-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pathogenetic Treatment With Strontium Ranelate in Women With Postmenopausal Osteoporosis

Modern Rheumatology Journal
2010English

Effects of Alendronate on the Markers of Bone Metabolic Activity in Postmenopausal Women With Osteoporosis

Medicinski Pregled
Medicine
2005English

Strontium Ranelate Reduces the Risk of Vertebral Fracture in Young Postmenopausal Women With Severe Osteoporosis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2008English

Distribution of Strontium and Mineralization in Iliac Bone Biopsies From Osteoporotic Women Treated Long-Term With Strontium Ranelate

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2011English

Long Treatment With Strontium Ranelate of Womenwith Postmenopausal Osteoporosis: 10-Year Results

Osteoporosis and Bone Diseases
2011English

Effects of Denosumab on Bone Density, Mass and Strength in Women With Postmenopausal Osteoporosis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2015English

The Effect of Strontium Ranelate Gel on Bone Formation in Calvarial Critical Size Defects

Open Access Macedonian Journal of Medical Sciences
Medicine
2017English

Polymeric Strontium Ranelate Nonahydrate

Acta Crystallographica Section E Structure Reports Online
2011English

Treatment of Post-Menopausal Osteoporosis by Strontium Ranelate in Everyday Practice – DUAL Study

Clinical & Experimental Pharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy